(Q40466103)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

review article

1 reference

title

A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

main subject

HIV transmission

0 references

prevention of HIV/AIDS

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1

M L Newell

1 reference

22 October 2019

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

274-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-199512040-00007

22 October 2019

exact match

0 references

cites work

Zidovudine-associated embryonic toxicity in mice

1 reference

12 December 2020

Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies

1 reference

12 December 2020

Mandatory Screening of Pregnant Women for the Human Immunodeficiency Virus

1 reference

12 December 2020

Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study

1 reference

12 December 2020

The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudi

1 reference

12 December 2020

Risk factors for vertical transmission of HIV-1 and early markers of HIV-1 infection in children.

1 reference

12 December 2020

Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues Ghent (Belgium), 17-20 February 1992. The Working Group on Mother-to-Child Transmission of HIV

1 reference

12 December 2020

Perinatal human immunodeficiency virus infection: ruminations on mechanisms of transmission and methods of intervention

1 reference

12 December 2020

Pharmacokinetic disposition of zidovudine during pregnancy

1 reference

12 December 2020

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group

1 reference

12 December 2020

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group

1 reference

12 December 2020

Mother to child transmission of human immunodeficiency virus 1 infection despite zidovudine therapy from 18 weeks of gestation

1 reference

12 December 2020

The growing impact of the HIV/AIDS pandemic on children born to HIV-infected women.

1 reference

12 December 2020

Working towards a European strategy for intervention to reduce vertical transmission of HIV.

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

Fetal toxicity of zidovudine (azidothymidine) in Macaca nemestrina: preliminary observations

1 reference

12 December 2020

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

1 reference

12 December 2020

Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV.

1 reference

12 December 2020

Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus

1 reference

12 December 2020

HIV-1 sensitivity to zidovudine and clinical outcome in children

1 reference

12 December 2020

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

12 December 2020

Where has HIV been hiding?

1 reference

12 December 2020

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee

1 reference

12 December 2020

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

1 reference

12 December 2020

Mother to child transmission of zidovudine-resistant HIV-1.

1 reference

12 December 2020

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

12 December 2020

Risk of human immunodeficiency virus type 1 transmission through breastfeeding

1 reference

12 December 2020

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

12 December 2020

Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.

1 reference

12 December 2020

Preclinical toxicology of zidovudine. An overview.

1 reference

12 December 2020

Zidovudine: five years later

1 reference

12 December 2020

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine

1 reference

12 December 2020

Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus

1 reference

12 December 2020

A survey of zidovudine use in pregnant women with human immunodeficiency virus infection

1 reference

12 December 2020

Birth outcomes following zidovudine therapy in pregnant women

1 reference

12 December 2020

Zidovudine use in pregnancy: a report on 104 cases and the occurrence of birth defects.

1 reference

12 December 2020

Zidovudine therapy of HIV-1 infection during pregnancy: assessment of the effect on the newborns.

1 reference

12 December 2020

10.2165/00002018-199512040-00007

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7646826%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

22 October 2019

1018546343

0 references

Fatcat ID

release_eztlrg6tfndozlfqjir2qyl754

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eztlrg6tfndozlfqjir2qyl754

24 November 2022

mapped directly with Wikidata item

1 reference